The therapeutic preparation of FVIIa having a purity of at least 1000 IU/mg of protein is characterized in that said preparation is free of proteins of non-human origin. In the method for obtaining FVII, purification starts from FrII+III, FrIII or equivalent of Cohn fractioning and comprises precipitation with PEG, chromatography and its subsequent activation.

 
Web www.patentalert.com

< Novel Agrochemical Formulations

> Methods for Regulating Gelation of Polysaccharide Solutions and Uses Thereof

> Drug and food or drink for improving pancreatic functions

~ 00517